Title : A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.

Pub. Date : 2013 Jun 1

PMID : 23553848






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Cabozantinib is an oral MET/VEGFR2 inhibitor. cabozantinib kinase insert domain receptor Homo sapiens